Joshua Grossman is a Rheumatology/Immunology physician. OpenAlex indexes 52 publications with 263 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
135 E 83rd St Apt 1a
New York, NY 100282420
Telephone
212-686-6321Provider last certified this registry record 6 Oct 2022.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20241 payment
- GENZYME CORPORATIONProgram year20241 payment
- Incyte CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
89.1%Histamine-1 Receptor Antagonist50%Azelastine Hcl100%Part D≥25 patientsLeukotriene Receptor Antagonist24.5%Montelukast Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
10.9%H2 blocker10.9%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Improved individual and population-level HbA1c estimation using CGM data and patient characteristics
Journal of Diabetes and its Complications
2021 - Improving Commercial Sign Regulations: A Preliminary Framework to Evaluate Commercial Sign Regulations in Texas2019
- Scoring system for differentiating perforated and non-perforated pediatric appendicitis
Emergency Radiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”